Shenequa McLeod, MD
Emergency Medicine · Rochester, NYNPI 1265756969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AstraZeneca at 27.6% of the total. Reporting peaked in 2021 at $996 and has fallen 97.5% since, to $24 in 2025. Among emergency medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $120.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$797
- Mallinckrodt Hospital Products Inc.$547
- Inari Medical, Inc.$327
- Genentech USA, Inc.$281
- Abiomed$173
- Mallinckrodt Enterprises LLC$150
- plus $617 from 6 others
What the payments were for
- Food & beverage$2,74495%
- Other$1495%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $797 |
| Mallinckrodt Hospital Products Inc. | 4 | $547 |
| Inari Medical, Inc. | 2 | $327 |
| Genentech USA, Inc. | 2 | $281 |
| Abiomed | 1 | $173 |
| Mallinckrodt Enterprises LLC | 1 | $150 |
| Baxter Healthcare | 1 | $149 |
| Portola Pharmaceuticals, LLC | 1 | $142 |
| AbbVie | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Abbott | 1 | $61 |
| Hologic Sales And Service, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$697
- LOKELMA$508
- ANDEXXA$396
- FLOWTRIEVER CATHETER, S$327
- CT THROMBECTOMY SYSTEM KIT$327
- Activase$281
- Impella$173
- DALVANCE$122
- ELIQUIS$120
How this compares
$2,893 in reported general payments places this provider in the 95th percentile of 4,167 emergency medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 12 | $101 |
| Prednisone | 26 | $32 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Rochester
- Suneel KoulRochester$6K
- David JanickeWilliamsville$441K
- Joseph BartBuffalo$315K
- Joseph HabbousheNew York$309K
- Adam SingerStony Brook$297K
- Sohan ParekhNew York$174K
- Benjamin AbellaNew York$143K
- David LevineCorning$138K
- Harry KopolovichBronx$131K
- Christopher RaioManhasset$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.